Problems, Pitfalls, and Testing Pearls

Why should you register now for this webinar?
• Hear national thought leaders discuss the laboratory’s critical role in laboratory diagnosis of hemophilia and challenges associated with monitoring factor replacement therapy
• Moderated by: Bob McGonnagle, Publisher, CAP TODAY
• Presenters: Dorothy M. Adcock, MD; Rajiv K. Pruthi, MBBS; and Stefan Tiefenbacher, PhD

Dorothy M. Adcock, MD, Medical Director, Colorado Coagulation, Laboratory Corporation of America Holdings, Englewood, CO (left); Rajiv K. Pruthi, MBBS, Associate Professor, Mayo Clinic College of Medicine, Co-Director, Special Coagulation Laboratory, Director Comprehensive Hemophilia Center, Mayo Clinic, Rochester, MN (center); Stefan Tiefenbacher, PhD, Vice President, Laboratory Corporation of America Holdings, Technical Director of CoagulatECMion, Colorado Coagulation, A LabCorp Speciality Testing Group, Englewood, CO (right).

What will this webinar empower you to do?
• Assess current issues and challenges related to accurate laboratory diagnosis of hemophilia
• Examine problems and pitfalls of clotting factor assays used to monitor factor replacement therapy
• Identify assay discrepancies and ensure consistency in the use of reference standards
• Ask your questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within. Jointly provided by Postgraduate Institute for Medicine the Cardiovascular & Metabolic Health Foundation, and Educational Concepts in Medicine. This activity is supported by an educational grant from Novo Nordisk Inc. Earn 1.0 AMA PRA Category 1 Credit™, 1.0 ANCC contact hour, or 1 ASCLS P.A.C.E.® contact hour. For full activity information please visit www.BloodCMECenter.org